TOI Short Volume
The Oncology Institute, Inc. (TOI) operates in the Healthcare sector, specifically the Medical - Care Facilities industry, with a market capitalization near $407.9M, listed on NASDAQ, employing roughly 825 people, carrying a beta of 0.36 to the broader market. The Oncology Institute, Inc. Led by Daniel Virnich, public since 2020-06-04.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-05-15
- Short Volume
- 195.2K
- Total Volume
- 460.4K
- Short %
- 42.39%
- 30-Day Avg Short %
- 41.91%
Showing 30 days of FINRA short volume data for The Oncology Institute, Inc..
Learn how short volume is reported and how to read the data →
Frequently asked TOI short volume questions
- What is the daily TOI short volume?
- As of May 15, 2026, The Oncology Institute, Inc. (TOI) short volume is 195.2K shares against 460.4K total reported volume, or 42.39% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is TOI short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does TOI short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.